USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Revenue (Most Recent Fiscal Year) | $854.50M |
Net Income (Most Recent Fiscal Year) | $42.03M |
PE Ratio (Current Year Earnings Estimate) | 12.26 |
PE Ratio (Trailing 12 Months) | 12.03 |
PEG Ratio (Long Term Growth Estimate) | 1.02 |
Price to Sales Ratio (Trailing 12 Months) | 0.65 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.13 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.51 |
Pre-Tax Margin (Trailing 12 Months) | 7.18% |
Net Margin (Trailing 12 Months) | 3.79% |
Return on Equity (Trailing 12 Months) | 9.48% |
Return on Assets (Trailing 12 Months) | 6.95% |
Current Ratio (Most Recent Fiscal Quarter) | 2.15 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.47 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 2.48 |
Book Value per Share (Most Recent Fiscal Quarter) | $29.06 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.74 |
Earnings per Share (Most Recent Fiscal Year) | $2.59 |
Diluted Earnings per Share (Trailing 12 Months) | $1.80 |
Exchange | NYSE |
Sector | Consumer Defensive |
Industry | Packaged Foods |
Common Shares Outstanding | 18.27M |
Free Float | 18.16M |
Market Capitalization | $586.71M |
Average Volume (Last 20 Days) | 0.11M |
Beta (Past 60 Months) | 0.61 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 0.63% |
Percentage Held By Institutions (Latest 13F Reports) | 54.25% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |